본문 바로가기 주메뉴 바로가기 하단메뉴 바로가기

GC녹십자MS

  • Contact / Q&A
  • recruitment
  • KOREA
  • SITEMAP
  • Company Introduction
  • Product Information
  • R&D
  • CSR
  • INVESTORS
 

R&D

With the goal of achieving ‘customer-oriented R&D’, we are focusing on establishing future technologies by expanding and deepening existing technologies.

R&D Fields

Print

Immunodiagnosis

With the increasing importance of early diagnosis in disease, there is a need for quicker and easier diagnosis techniques. Various immunological diagnostic methods are being studied and developed. Advancement of diagnostic methods presents higher sensitivity, specificity and convenience. GCMS Immunodiagnostics is continuously expanding its domestic market share on the basis of its diverse product portfolio. To target the immunodiagnostic market, the largest market in the global diagnostic reagent field, we take persistent efforts in development and diversification of our product portfolio. We will enhance our competitiveness and increase revenue by development of raw materials for diagnosis.
GCMS will be a domestically and globally well-recognized leading company dedicated to diagnostics.